Since launching in August 2011, the Surefire Infusion System has been used in more than 100 high-volume hospitals in the United States. Among those hospitals are several that are listed as Top Hospitals, according to U.S. News & World Report‘s 2013 Edition of Best Hospitals.

Surefire’s Infusion System has been used by physicians to perform procedures in 20 of the top 50 Cancer Hospitals, as ranked by U.S. News & World Report, including 8 of the top 17 Honor Roll Hospitals.


Clinical Data Shows Surefire Technology Achieved 79% Objective Response versus 37% Using a Standard Microcatheter in Treating Primary Liver Cancer. Study presented at SIR 2017 Annual Scientific Meeting.